Pharma Journalist - Page 662 of 924 -

Roche Acquires PathAI to Expand Digital Pathology Business

Altasciences, Certara Partner to Speed Early Drug Development

Angelini Pharma to Acquire Catalyst in $4.1 Billion Deal

Recipharm to potentially end operations in Ashton-under-Lyne facility

Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon

Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies

Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies

Novartis announces offer to acquire CellforCure to expand manufacturing capacity for innovative cell and gene therapies

Novartis announces new CEO of Oncology Business Unit

Astellas & Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI (enzalutamide) in Men with mHSPC

Lynparza meets primary endpoint in Phase III SOLO-3 trial

Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T)

WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership